Dr.E.T.’s Concierge Care was awarded the 2017 Innovation award by the Kansas City Medical Society
Acute and chronic economic hardships are the little recognized but all too common effects of cancer therapy, new research shows. Mean annual medical expenditures are higher for male cancer survivors than for males without a history of cancer ($8091 vs $3094), according to a study published in the June 13 issue of the Morbidity and Mortality Weekly Report. For female cancer survivors, costs were even higher ($8412 vs $5119). In addition to out-of-pocket costs, men with a history of cancer lost an estimated $3700 in annual productivity, and women lost an estimated $4000, write Donatus U. Ekwueme, PhD, from the division of cancer prevention and control at the National Center for Chronic Disease Prevention and Health Promotion, US Centers for Disease Control and Prevention (CDC), in Atlanta, and colleagues. These average annual productivity losses compared unfavorably with the $2260 for cancer-free males and the $2703 for cancer-free females. Employment disability accounted for about 75% of the productivity loss in male and female survivors. “The economic data presented in this report investigating the economic consequences of surviving cancer highlight the need to develop comprehensive intervention programs to improve the quality of the cancer survivorship experience and decrease the economic burden of cancer survivorship in the United States,” the authors write. One new and sligh
Dr.E.T.’s Concierge Care is now available at KC Urology Care for KCUC patients.
New England Journal of Medicine
http://www.wsj.com/articles/i-was-wrong-about-obamacare-1469997311 Large health systems deliver “personalized” care in the same way that GM can sell you a car with the desired options. Yet personal relationships of the kind often found in smaller practices are the key to the practice of medicine. They are the relationships that doctors want to forge with patients, and vice versa. It may sound old-fashioned, but what I have learned is that we do not need to sacrifice this unique feature of our health-care system as we move forward in adapting new value-based payment models and improving the health of patients.
WSJ By ANNA WILDE MATHEWS Updated Sept. 14, 2016 12:30 p.m. ET 199 COMMENTS The average cost of health coverage offered by employers pushed above $18,000 for a family plan this year, though the growth was slowed by the accelerating shift into high-deductible plans, according to a major survey. Annual premium cost rose 3% to $18,142 for an employer family plan in 2016, from $17,545 last year, according to the annual poll of employers performed by the nonprofit Kaiser Family Foundation along with the Health Research & Educational Trust, a nonprofit affiliated with the American Hospital Association. Employees paid 30% of the premiums for a family plan in 2016, compared with 29% last year, according to Kaiser. For an individual worker, the average annual cost of employer coverage was $6,435 in this year’s survey, with employees paying 18% of that total. The change in annual premium for individual coverage from 2015 wasn’t statistically significant. Economists have long debated the reasons for the slow pace of growth in premiums, which has continued for several years. Some have argued that the limited rate of increase is primarily linked to aftereffects of the recession and continued economic uncertainty. But the newest Kaiser survey highlights the effects of another shift: the continuing growth of plans that involve higher out-of-pocket costs in the form of deductibles. Kai
What Doctors Know About How Bad It Is, and Won’t Say Until a severe stroke sent him to a neurological intensive care unit in December 2014, Ernest Kohn was a particularly vibrant 90-year-old, still teaching a graduate economics class at Queens College. So his family thought he might rebound. But when his son, Jerry, asked the rotating flotilla of neurologists what was likely to happen — would his father survive? go home? — no one really wanted to address his questions. “When you pushed them, they said, ‘We can’t say anything with surety,’” Mr. Kohn said. “I kept saying, ‘I’m only asking for your opinion, not a guarantee. I’d really like to know what your 30 years of medical knowledge and experience tell you.’ Most of them would just clam up.” We’ve known for years that doctors hesitate or even decline to discuss a poor prognosis with patients and their families. They fear that bad news will dash hopes; they don’t want to appear to be giving up. Often, their training hasn’t prepared them for sensitive conversations